A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer

European Journal of Surgical Oncology

Volumn 28, Issue 6, 2002, Pages 603-614

  Bevilacqua, J L B ^a,b,c   Gucciardo, G ^d   Cody, H S ^e   MacDonald, K A ^e   Sacchini, V ^e   Borgen, P I ^e   Van Zee, K J ^e  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b Inst Brasileiro de Controle Cancer   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Axillary metastases prognosis; Breast carcinoma; Internal mammary; Lymph nodes; Sentinel lymph nodes; Tumour location

Indexed keywords

ALGORITHM; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 0036740242     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2002.1269     Document Type: Review

References (84)

1. Cody HS III, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995; 2: 32-7.
2. Li YYK, Shen ZZ. An analysis of 1,242 cases of extended radical mastectomy. Breast, Dis Breast 1984; 10: 10-19.
3. Sugg SL, Ferguson DJ, Posner MC. Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol 2000; 7: 188-92.
4. Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202: 702-7.
5. Veronesi U, Marubini E, Mariani L, et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-Year results of a randomised trial. Eur J Cancer 1999; 35: 1320-5.
6. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-80.
7. Anderson BO, Bensinger W, Cox CE, et al. NCCN practice guidelines for breast cancer. Oncology (Hunting) 2000; 14: 33-49.
8. Jansen L, Doting MH, Rutgers EJ, et al. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 2000; 87: 920-5.
9. Johnson N, Soot L, Nelson J, et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg 2000; 179: 386-8.
10. Noguchi M, Tsugawa K, Miwa K. Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol 2000; 73: 75-80.
11. American Joint Committee on Cancer. AJCC Cancer Staging Manual (5th edn). Philadelphia, PA: Lippincott-Raven, 1997: 171-80.
12. Bevilacqua JLB, Cody HS III, MacDonald KA, et al. A model for predicting axillary node metastases based on 2000 sentinel node procedures and tumour location. Eur J Surg Oncol 2002; 28: 490-500.
13. Fein DA, Fowble BL, Hanlon AL, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol 1997; 65: 34-9.
14. Gann PH, Colilla SA, Gapstur SM, et al. Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses. Cancer 1999; 86: 1511-19.
15. Halverson KJ, Taylor ME, Perez CA, et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 1994; 17: 461-6.
16. Maibenco DC, Weiss LK, Pawlish KS, et al. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer 1999; 85: 1530-6.
17. Olivotto IA, Jackson JS, Mates D, et al. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis. Cancer 1998; 83: 948-55.
18. Urban JA. Clinical experience and results of excision of the internal mammary lymph node chain in the primary operable breast cancer. Cancer 1959; 12: 14-22.
19. Velanovich V, Szymanski W. Lymph node metastasis in breast cancer: common prognostic markers lack predictive value. Ann Surg Oncol 1998; 5: 613-19.
20. Voogd AC, Coebergh JW, Repelaer van Driel OJ, et al. The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis. Breast Cancer Res Treat 2000; 62: 63-9.
21. Turner-Warwick RT. The lymphatics of the breast. Br J Surg 1959; 46: 574-82.
22. Stibbe EP. The internal mammary lymphatic glands. J Anat 1918; 52: 257-64.
23. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
24. Guenther JM, Collins JC, Barnes G Jr et al. Selective lymphoscintigraphy: a necessary adjunct to dye-directed sentinel node biopsy for breast cancer? Arch Surg 2000; 135: 1101-5.
25. Kamath V, Ramnath EM, Shivers S, et al. Role of lymphoscintigraphy for lymphatic mapping in women with breast cancer (abstract I). In: 53rd Annual Cancer Symposium of Society of Surgical Oncology, New Orleans, LA, 16-19 March 2000 (abstract).
26. O'Hea BJ, Hill AD, El Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-7.
27. Urban JA, Baker HW. Radical mastectomy in continuity with en bloc resection of the internal mammary lymph node chain - a new procedure for primary operable cancer of the breast. Cancer 1952; 5: 992-1008.
28. Caceres E. Incidence of metastases in the internal mammary chain in operable cancer of the breast. Surg Gynecol Obstet 1959; 108: 715-20.
29. Sugarbaker ED. Extended radical mastectomy. J Am Med Assoc 1964; 187: 96-8.
30. Dahl-Iversen E, Tobiassen T. Radical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma. Ann Surg 1969; 170: 889-91.
31. Livingston SF, Arlen M. The extended extrapleural radical mastectomy: its role in the treatment of carcinoma of the breast. Ann Surg 1974; 179: 260-5.
32. Lacour J, Bucalossi P, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer 1976; 37: 206-14.
33. Lacour J, Le M, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer 1983; 51: 1941-3.
34. Rai S, Jindal RP, Nijjer SS. Internal mammary lymph node metastasis in carcinoma. Indian J Cancer 1980; 17: 169-71.
35. Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981; 47: 170-5.
36. Morimoto T, Monden Y, Takashima S, et al. Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer. Surg Today 1994; 24: 210-14.
37. McDonald JJ, Haagensen CD, Stout AP. Metastasis from mammary carcinoma to the supraclavicular and internal mammary lymph nodes. Surgery 1953; 34: 521-42.
38. Wyatt JP, Sugarbaker ED, Stanton MF. Involvement of internal mammary lymph nodes in carcinoma of the breast. Am J Pathol 1955; 31: 143-50.
39. Hutchinson WB, Kiriluk LB. Internal mammary node investigation in carcinoma of the breast. Am J Surg 1956; 92: 151-5.
40. Pavrovsky J, Tersip K, Palecek L. Results of radical operation for mammary gland carcinoma with revision of the parasternal space. Int Surg 1969; 51: 509-14.
41. Bucalossi P, Veronesi U, Zingo L, et al. Enlarged mastectomy for breast cancer. Review of 1, 213 cases. Am J Roentgenol Radium Ther Nucl Med 1971; 111: 119-22.
42. Urban JA, Castro EB. Selecting variations in extent of surgical procedure for breast cancer. Cancer 1971; 28: 1615-23.
43. Richardson JD, Meeker WR, Jewell WR. The morbidity of the extended radical versus the standard radical mastectomy. J Ky Med Assoc 1972; 70: 537-9.
44. Caceres E. Radical and extended surgery for cancer. Surg Annu 1973; 5: 55-67.
45. Handley RS. Carcinoma of the breast. Ann R Coll Surg Engl 1975; 57: 59-66.
46. Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer 1977; 39: 533-8.
47. Deemarski LY, Seleznev IK. Extended radical operations on breast cancer of medial or central location. Surgery 1984; 96: 73-7.
48. Horino T, Fujita M, Ueda N et al. Efficacy of internal mammary node dissection in the treatment of breast cancer. Jpn J Clin Oncol 1991; 21: 422-7.
49. . Noguchi M, Ohta N, Koyasaki N, et al. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 1991; 68: 1918-25.
50. Margottini M. Recent developments in the surgical treatment of breast carcinoma. Acta Unio Internat Contra Cancrum 1952; 8: 176-8.
51. Lohrisch C, Jackson J, Jones A, et al. Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer. J Clin Oncol 2000; 18: 2828-35.
52. Zucali R, Mariani L, Marubini E, et al. Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 1998; 16: 1363-6.
53. Asaga T, Masuzawa T, Yoshida A, et al. Location of breast cancer as a prognostic factor. Breast Cancer Res Treat 1994; 32: S48 (abstract).
54. Israel L, Gogeul E, Morere JF, et al. Distinct metastatic pattern in breast tumor of inner and central areas. In: Proceedings of the Annual Meeting of the American Society of Clinical Oncology. Vol. 14. 1995; A110 (abstract).
55. Meyer W. An improved method of the radical operation for carcinoma of the breast. Med Rec 1894; 46: 746-9.
56. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312: 665-73.
57. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981; 305: 6-11.
58. Fisher B, Slack NH, Cavanaugh PJ et al. Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial. Ann Surg 1970; 172: 711-32.
59. Host H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer - long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 1986; 12: 727-32.
60. Palmer MK, Ribeiro GG. Thirty-four year follow up of patients with breast cancer in clinical trial of postoperative radiotherapy. Br Med J (Clin Res Edn) 1985; 291: 1088-91.
61. Veronesi U, Zucali R, Luini A. Local control and survival in early breast cancer: the Milan trial. Int J Radiat Oncol Biol Phys 1986; 12: 717-20.
62. Yamashita T, Hurukawa M, Sekiguchi K. et al. Efficacy of locoregional lymphnodes irradiation after mastectomy for breast cancer with biopsy proven parasternal lymph node metastases - a randomized study (abstract 1066). In: 38th Annual American Society for Therapeutic Radiology and Oncology Meeting, Los Angeles, CA, 27-30 October 1996 (abstract).
63. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b. N Engl J Med 1997; 337: 949-55.
64. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956-62.
65. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000; 18: 1220-9.
66. Obedian E, Haffty BG. Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit? Int J Radiat Oncol Biol Phys 1999; 44: 997-1003.
67. Fowble B, Hanlon A, Freedman G, et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 2000; 47: 883-94.
68. Freedman GM, Fowble BL, Nicolaou N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 2000; 46: 805-14.
69. Cody HS III, Borgen PI. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 1999; 8: 85-91.
70. Cody HS III. Clinical aspects of sentinel node biopsy. Breast Cancer Res 2001; 3: 104-8.
71. Burak WE Jr, Walker MJ, Yee LD, et al. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 1999; 177: 445-9.
72. Cox CE, Dupont E, Peltz ES, et al. Preoperative detection of internal mammary lymph nodes using lymphoscintigraphy and intraoperative lymphatic mapping for breast cancer mandates excision (abstract 67). In: 53rd Annual Cancer Symposium of the Society of Surgical Oncology, Washington, DC, 15-18 March 2001 (abstract).
73. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998; 339: 941-6.
74. Roumen RM, Geuskens LM, Valkenburg JG. In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 1999; 25: 347-51.
75. Snider H, Dowlatshahi K, Fan M, et al. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998; 176: 305-10.
76. van der Ent FW, Kengen RA, van der Pol HA, et al. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 1999; 25: 24-9.
77. Winchester DJ, Sener SF, Winchester DP, et al. Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered technetium 99m sulphur colloid with overnight migration time. J Am Coll Surg 1999; 188: 597-603.
78. Zurrida S, Galimberti V, Orvieto E, et al. Radioguided sentinel node biopsy to avoid axillary dissection in breast cancer. Ann Surg Oncol 2000; 7: 28-31.
79. Boolbol SK, Fey JV, Borgen PI, et al. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 2001; 8: 20-4.
80. Linehan DC, Hill AD, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 1999; 6: 450-4.
81. Weiser MR, Montgomery LL, Susnik B, et al. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol 2000; 7: 651-5.
82. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998; 351: 1451-67.
83. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998; 352: 930-42.
84. Fisher B, Dignam J, Tan-Chiu E, et al. Prognosis and treatment of patients with breast tumours of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst 2001; 93: 112-20.